This document provides background information on a WHO consultation regarding guidance on viral hepatitis prevention, surveillance, and treatment. It summarizes statistics on hepatitis B and C infections globally and among people who inject drugs. It also describes the negative impact of HIV co-infection on hepatitis disease progression. To inform the guidance, interviews were conducted with community members and healthcare providers affected by or working on viral hepatitis across various world regions. Their perspectives will provide insights into the individual challenges faced by those impacted by the guidance.